SIGMA GBS™ for Faster Screening of Group B Streptococcus

Sigma GBS™ is a swab based device for the direct collection and rapid processing of screening specimens for Streptococcus agalactiae (commonly known as Group B Streptococcus).
Group B Strep

Sigma GBS™ is a swab based device for the direct collection and rapid processing of screening specimens for Streptococcus agalactiae (commonly known as Group B Streptococcus). Streptococcus agalactiae is a leading cause of illness in newborn babies, and can result in death or serious life changing consequences.

The organism may be carried asymptomatically by the mother, but can then be passed onto the baby during labour. Policies vary, but in some countries there is now a screening programme to identify carriers with a view to offering antibiotics during labour. Other countries may not have universal screening, but there is still increased testing of those deemed to be at most risk of being carriers.

The Sigma GBS™ device consists of a vial of Lim broth enrichment medium and a swab which can be snapped into the vial. The swab is used to collect specimen in normal way from vagina or rectum in accordance with local procedures.

After collecting the specimen, the vial is incubated at 37OC before inoculation onto a suitable chromogenic agar medium for the direct detection and identification of Streptococcus agalactiae. Lim Broth medium will promote growth of Streptococcus agalactiae, while inhibiting any growth of other bacteria such as E. coli which would often be present in the same specimens.

The vial is compatible with all current automated processing platforms, while if a more rapid diagnosis is required, the specimen can be tested using molecular methods.

  • Convenient format for screening for Group B Streptococcus colonisation
  • Lim Broth Medium
  • Enrichment of specimens ready for direct plating on chromogenic agar
  • Interfering bacteria inhibited, including E. coli
  • Simpler processing and faster turnaround
  • Convenient Snap ‘n’ Cap format for easy specimen handling
  • Liquid format compatible with automated processing platforms

 

Share this page

Related Clinical studies

Adenovirus – What do we know and what is new?

Recently, the World Health Organisation (WHO) released a report on acute hepatitis in children with an unknown origin. Even though Adenovirus is a hypothesis as being one of the strongly associated reasons for Hepatitis in this report, it is still under investigation. United Kingdom is one of the highly affected countries. PCR analysis has been the first line of diagnosis. Blood sampling, respiratory sampling and stool sampling are being used to collect specimen. Respiratory specimen in a VTM such as the ∑-Virocult® (Viral transport media) and ∑-MM™ inactivation media can be used to collect samples.

Read More »

Polio – what can we do to prevent it?

Poliovirus can be cultured from faeces which usually goes through a prolonged cell culture process. MWE’s Faecal Transwab® compatible with PCR, would be a suitable medium to collect and transport the sample to the laboratory if faecal sample was not readily available or desirable.

Read More »

Contact us

Have a question or would like to find out about one of our products? Please fill in the form below and we’ll be in touch soon.

Contact Popup

Product enquiry

For buying enquiries, or for more information about this product, please fill in the form below and we’ll be in touch soon.

Product enquiry

Let’s see...

We can direct you to the best place. Would you like help with:

Need help?
Choice